Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG40011)
Regulator Name | CircGFRA1 (circRNA) | ||||
---|---|---|---|---|---|
Synonyms |
CircGFRA1
Click to Show/Hide
|
||||
Gene Name | CircGFRA1 | ||||
Regulator Type | circRNA |
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
CircGFRA1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Ferroptosis suppressor protein 1 (AIFM2) [Suppressor]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Breast cancer | ICD-11: 2C60 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell infiltration | |||||
Cell migration | |||||
In Vitro Model |
SK-BR-3 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0033 | |
BT-474 cells | Invasive breast carcinoma | Homo sapiens | CVCL_0179 | ||
In Vivo Model |
Female BALB/c nude mice aged 4 weeks were administered subcutaneously with 2 x 106 cells (five mice/group). After that, the mice were given intratumoural inoculation of 40 uL si-circGFRA1 or si-NC every 4 days. To detect lung metastases, we intravenously inoculated 1 x 105 cells into the tail veins of mice (six mice/group). After the elapse of 8 weeks, we anaesthetized the mice, harvested their lungs and visually counted the metastatic nodules in the lungs, followed by validation via H&E staining and counting under a microscope.
Click to Show/Hide
|
||||
Response regulation | Knockdown of circGFRA1 could attenuate HER-2-positive HER-2-positive breast cancer progression by inhibiting the proliferation, infiltration and migratory ability of HER-2-positive BC cells. Through ceRNA mechanism, circGFRA1 could bind to miR-1228 and alleviate inhibitory activity of miR-1228 on targeted gene AIFM2. | ||||
Breast cancer [ICD-11: 2C60]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | CircGFRA1 (circRNA) | circRNA | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell infiltration | |||||
Cell migration | |||||
In Vitro Model |
SK-BR-3 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0033 | |
BT-474 cells | Invasive breast carcinoma | Homo sapiens | CVCL_0179 | ||
In Vivo Model |
Female BALB/c nude mice aged 4 weeks were administered subcutaneously with 2 x 106 cells (five mice/group). After that, the mice were given intratumoural inoculation of 40 uL si-circGFRA1 or si-NC every 4 days. To detect lung metastases, we intravenously inoculated 1 x 105 cells into the tail veins of mice (six mice/group). After the elapse of 8 weeks, we anaesthetized the mice, harvested their lungs and visually counted the metastatic nodules in the lungs, followed by validation via H&E staining and counting under a microscope.
Click to Show/Hide
|
||||
Response regulation | Knockdown of circGFRA1 could attenuate HER-2-positive HER-2-positive breast cancer progression by inhibiting the proliferation, infiltration and migratory ability of HER-2-positive BC cells. Through ceRNA mechanism, circGFRA1 could bind to miR-1228 and alleviate inhibitory activity of miR-1228 on targeted gene AIFM2. | ||||